Salt Lake City-based Echelon Biosciences has been acquired by VION Biosciences, a life science platform company based in Charlottesville, Virginia. Echelon is a medical and biological materials developer located on the University of Utah campus. VION manufactures specialty reagents in the life science research, diagnostic and drug discovery space.
VION Biosciences is a portfolio company of Nashville, Tennessee-based Iron Path Capital and is led by life science industry veteran Mark Thornton.
“Joining forces with VION Biosciences provides an exciting opportunity to amplify the impact of our products and technologies,” said Bert V. Israelsen, former Echelon owner and president. “The combination of the team at Echelon and the Please log in to see the rest of this story.
